BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Costiniuk CT, Jenabian MA. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment? Cytokine Growth Factor Rev 2020;53:63-5. [PMID: 32467020 DOI: 10.1016/j.cytogfr.2020.05.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun W, He L, Lou H, Fan W, Yang L, Cheng G, Liu W, Sun L. The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs. Front Immunol 2022;13:898520. [PMID: 35757743 DOI: 10.3389/fimmu.2022.898520] [Reference Citation Analysis]
2 Fonnesu R, Thunuguntla VBSC, Veeramachaneni GK, Bondili JS, La Rocca V, Filipponi C, Spezia PG, Sidoti M, Plicanti E, Quaranta P, Freer G, Pistello M, Mathai ML, Lai M. Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor. Viruses 2022;14:1080. [DOI: 10.3390/v14051080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ashtar Nakhaei N, Najarian A, Farzaei MH, Norooznezhad AH. Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story? J Cannabis Res 2022;4. [DOI: 10.1186/s42238-022-00129-w] [Reference Citation Analysis]
4 Vallée A. Cannabidiol and SARS-CoV-2 Infection. Front Immunol 2022;13:870787. [DOI: 10.3389/fimmu.2022.870787] [Reference Citation Analysis]
5 Wang B, Li D, Fiselier A, Kovalchuk I, Kovalchuk O. New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-022-00876-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Palmos AB, Millischer V, Menon DK, Nicholson TR, Taams LS, Michael B, Sunderland G, Griffiths MJ, Hübel C, Breen G; COVID Clinical Neuroscience Study Consortium. Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19. PLoS Genet 2022;18:e1010042. [PMID: 35239653 DOI: 10.1371/journal.pgen.1010042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Odieka AE, Obuzor GU, Oyedeji OO, Gondwe M, Hosu YS, Oyedeji AO. The Medicinal Natural Products of Cannabis sativa Linn.: A Review. Molecules 2022;27:1689. [DOI: 10.3390/molecules27051689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Pereira CF, Vargas DD, Toneloto FL, Ito VD, Volpato RJ. Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review. Rev Bras Enferm 2022;75:e20201374. [DOI: 10.1590/0034-7167-2020-1374] [Reference Citation Analysis]
9 Mahmud MS, Hossain MS, Ahmed ATMF, Islam MZ, Sarker ME, Islam MR. Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review. Molecules 2021;26:7216. [PMID: 34885798 DOI: 10.3390/molecules26237216] [Reference Citation Analysis]
10 Onay A, Ertaş A, Süzerer V, Yener İ, Yilmaz MA, Ayaz-Tilkat E, Ekinci R, Bozhan N, Irtegün-Kandemir S. Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy? Turk J Biol 2021;45:570-87. [PMID: 34803455 DOI: 10.3906/biy-2105-73] [Reference Citation Analysis]
11 Sun W, Zhang H, Fan W, He L, Chen T, Zhou X, Qi Y, Sun L, Hu R, Luo T, Liu W, Li J. Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)-Peptide Tetramers. Viruses 2021;13:2264. [PMID: 34835070 DOI: 10.3390/v13112264] [Reference Citation Analysis]
12 Rabino M, Mallia S, Castiglioni E, Rovina D, Pompilio G, Gowran A. The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases. Pharmaceuticals (Basel) 2021;14:936. [PMID: 34577636 DOI: 10.3390/ph14090936] [Reference Citation Analysis]
13 Scheau C, Caruntu C, Badarau IA, Scheau AE, Docea AO, Calina D, Caruntu A. Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier. J Pers Med 2021;11:494. [PMID: 34072930 DOI: 10.3390/jpm11060494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Garg H, Khanna P. COVID-19 and Cannabis: Playing Saint or Devil? Eurasian J Med 2021;53:162-3. [PMID: 34177305 DOI: 10.5152/eurasianjmed.2021.20275] [Reference Citation Analysis]
15 Jha NK, Sharma C, Hashiesh HM, Arunachalam S, Meeran MN, Javed H, Patil CR, Goyal SN, Ojha S. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Front Pharmacol 2021;12:590201. [PMID: 34054510 DOI: 10.3389/fphar.2021.590201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jakowiecki J, Abel R, Orzeł U, Pasznik P, Preissner R, Filipek S. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling. Molecules 2021;26:2456. [PMID: 33922473 DOI: 10.3390/molecules26092456] [Reference Citation Analysis]
17 Pereira GJDS, Leão AHFF, Erustes AG, Morais IBM, Vrechi TAM, Zamarioli LDS, Pereira CAS, Marchioro LO, Sperandio LP, Lins ÍVF, Piacentini M, Fimia GM, Reckziegel P, Smaili SS, Bincoletto C. Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19. Int J Mol Sci 2021;22:4067. [PMID: 33920748 DOI: 10.3390/ijms22084067] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
18 Moreno E, Cavic M, Canela EI. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease. Int J Mol Sci 2021;22:3661. [PMID: 33915889 DOI: 10.3390/ijms22073661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lucaciu O, Aghiorghiesei O, Petrescu NB, Mirica IC, Benea HRC, Apostu D. In quest of a new therapeutic approach in COVID-19: the endocannabinoid system. Drug Metab Rev 2021;:1-13. [PMID: 33683968 DOI: 10.1080/03602532.2021.1895204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kaggwa MM, Bongomin F, Najjuka SM, Rukundo GZ, Ashaba S. Cannabis-Induced Mania Following COVID-19 Self-Medication: A Wake-Up Call to Improve Community Awareness. Int Med Case Rep J 2021;14:121-5. [PMID: 33658866 DOI: 10.2147/IMCRJ.S301246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Malinowska B, Baranowska-Kuczko M, Kicman A, Schlicker E. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19. Int J Mol Sci 2021;22:1986. [PMID: 33671463 DOI: 10.3390/ijms22041986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 O'Sullivan SE, Stevenson CW, Laviolette SR. Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders? Cannabis Cannabinoid Res 2021;6:7-18. [PMID: 33614948 DOI: 10.1089/can.2020.0102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Furgiuele A, Cosentino M, Ferrari M, Marino F. Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review. J Neuroimmune Pharmacol 2021;16:251-69. [PMID: 33492630 DOI: 10.1007/s11481-021-09982-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
24 Kotru S, Klimuntowski M, Ridha H, Uddin Z, Askhar AA, Singh G, Howlader MMR. Electrochemical sensing: A prognostic tool in the fight against COVID-19. Trends Analyt Chem 2021;136:116198. [PMID: 33518850 DOI: 10.1016/j.trac.2021.116198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
25 Ghati A, Dam P, Tasdemir D, Kati A, Sellami H, Sezgin GC, Ildiz N, Franco OL, Mandal AK, Ocsoy I. Exogenous pulmonary surfactant: A review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including SP-A and SP-D as added clinical marker. Curr Opin Colloid Interface Sci 2021;51:101413. [PMID: 33390762 DOI: 10.1016/j.cocis.2020.101413] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
26 Pesce M, Seguella L, Cassarano S, Aurino L, Sanseverino W, Lu J, Corpetti C, Del Re A, Vincenzi M, Sarnelli G, Esposito G. Phytotherapics in COVID19: Why palmitoylethanolamide? Phytother Res 2020. [PMID: 33296131 DOI: 10.1002/ptr.6978] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? Phytomedicine 2021;85:153396. [PMID: 33380375 DOI: 10.1016/j.phymed.2020.153396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
28 Onaivi ES, Sharma V. Cannabis for COVID-19: can cannabinoids quell the cytokine storm? Future Sci OA 2020;6:FSO625. [PMID: 32974048 DOI: 10.2144/fsoa-2020-0124] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]